Mette Kruse Klausen, Signe Keller Justesen, Julie Niemann Pedersen, et al.: Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trial , in: The Lancet, Mai 2026
At the same time, viral anecdotes about Ozempic erectile dysfunction have fueled anxiety
Energy Expenditure: Pre-clinical studies have highlighted Retatrutides GCGR-driven energy expenditure component as a particularly significant differentiator, with research documenting thermogenic and hepatic fat oxidation effects that add a distinct metabolic dimension beyond the appetite suppression and insulin secretion pathways shared with Tirzepatide and Semaglutide
Will I regain the weight I lost if I stop taking it
Lets walk through how to do it right
Here are some strategies for keeping tabs on your intake if youre on a GLP-1